Transcript Slide 1

Xavier University of Louisiana
College of Pharmacy
Curriculum Map – NAPLEX Competencies
Map by Competency
1
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a
disease or medical condition, assess the need for treatment and/or referral, and identify
patient-specific factors that effect health, pharmacotherapy, and/or disease management
1.1.1 – Identify and assess patient information including medication, laboratory and
disease state histories.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM - I
I
L
T
Biopharmaceutics
I
L
HW, T
Pharmacy
Practice
E
CS
Lab
DSM – II
R, E
L, VT, CS, O
T, IGP
IPPE – III
R
SGD, O
OP, IGP
Clinical Rotation
R, E
SGD, O, CS
OP, IGP, T, Q, D, O
2
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the
presence of a disease or medical condition, assess the need for treatment
and/or referral, and identify patient-specific factors that effect health,
pharmacotherapy, and/or disease management
1.1.2 – Identify and/or use instruments and techniques related to patient
assessment and diagnosis.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pathophysiology
I
L, CS
T
DSM – I
I
L
T
Pharmacy
Practice
E
VT, CS, GS
OP, IGP, Lab, D
DSM – II
R
L
?
DSM – III
I, E
L, CS
T, IGP
3
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the
presence of a disease or medical condition, assess the need for treatment
and/or referral, and identify patient-specific factors that effect health,
pharmacotherapy, and/or disease management
1.1.2 – Identify and/or use instruments and techniques related to patient
assessment and diagnosis.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
IPPE – III
E
SGD, O
OP
Clinical Rotation
R, E
SGD, OP, O, CS
OP, IGP, Q, D
4
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the
presence of a disease or medical condition, assess the need for treatment
and/or referral, and identify patient-specific factors that effect health,
pharmacotherapy, and/or disease management
1.1.3 – Identify and define the terminology, signs and symptoms associated
with diseases and medical conditions.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Biochemistry
I
L
T
Med. Chem. I
I
L
T
Pathophysiology
I
CS, L
T
DSM – I
I
L
T
Med. Chem. II
R
L
T
5
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the
presence of a disease or medical condition, assess the need for treatment
and/or referral, and identify patient-specific factors that effect health,
pharmacotherapy, and/or disease management
1.1.3 – Identify and define the terminology, signs and symptoms associated
with diseases and medical conditions.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM – II
R
L
T
DSM – III
I, E
L, CS, O
T, IGP
IPPE – III
E
SGD, O
IGP, OP
Clinical Rotation
R
SGD, CS, O
OP, IGP, O
6
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the
presence of a disease or medical condition, assess the need for treatment
and/or referral, and identify patient-specific factors that effect health,
pharmacotherapy, and/or disease management
1.1.4 – Identify and evaluate patient factors, genetic factors, biosocial factors,
and concurrent drug therapy that are relevant to the maintenance of wellness
and the prevention or treatment of a disease or medical condition.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Med. Chem. I
I
L
T
DSM – I
I
L
T
Biopharmaceutics
I
L
HW, T
Pharmacy
Practice
E
CS
Lab
7
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the
presence of a disease or medical condition, assess the need for treatment
and/or referral, and identify patient-specific factors that effect health,
pharmacotherapy, and/or disease management
1.1.4 – Identify and evaluate patient factors, genetic factors, biosocial factors,
and concurrent drug therapy that are relevant to the maintenance of wellness
and the prevention or treatment of a disease or medical condition.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM – II
R
L
T
DSM – III
I, E
L, VT, CS, O
T, IGP
IPPE – III
R
SGD
O,OP, IGP
Clinical Rotation
I, R, E
SGD, CS, O
OP, Q, IGP, O
8
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.1 – Identify specific uses and indications for drug products.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Biochemistry
I
L
T
Pharmaceutics
I
?
?
Med. Chem. I
I
L
T
DSM – I
I
L
T
Med. Chem. II
I
L
T
Biopharmaceutics
R
L
HW, T
9
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.1 – Identify specific uses and indications for drug products.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy
Practice
E
CS
Q, OP, IGP, Lab
DSM – II
R
L
T
DSM – III
R, E
L, CS, O
T, IGP
IPPE – III
R
SGD
IGP, OP
Clinical Rotation
R, E
SGD, CS, O
T, Q, OP, HW,
IGP, D
10
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.2 – Identify the known or postulated sites and mechanisms of action of
pharmacotherapeutic agents.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Principles of Drug
Action
I
L
T, Q
Med. Chem. I
I
L
T
P. Sciences Lab
I, R
L
IGP, Lab, D, T
DSM – I
R
L
T
Med. Chem. II
I
L
T
11
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.2 – Identify the known or postulated sites and mechanisms of action of
pharmacotherapeutic agents.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy
Practice
E
CS
Q, OP, IGP, Lab
DSM – II
R
L
T
DSM – III
R, E
L, VT, CS, O
T, IGP
IPPE – III
R
SGD, O
OP, IGP
Clinical Rotation
R, E
CS, SGD, O
Q, T, OP, D
12
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.3 –Evaluate drug therapy for the presence of pharmacotherapeutic
duplications and interactions with other drugs, food, diagnostic tests, and
monitoring procedures.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Med. Chem. I
I
L
T
DSM – I
I
CS
?
Pharmacy
Practice
E
CS
OP, HW, IGP, Lab
DSM – II
R
L
T
DSM – III
I, E
L, CS
T, IGP
13
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.3 –Evaluate drug therapy for the presence of pharmacotherapeutic
duplications and interactions with other drugs, food, diagnostic tests, and
monitoring procedures.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
IPPE – III
R
SGD, O
OP, IGP
Clinical Rotation
R, E
CS, SGD, O
Q, RP, P, OP, D
14
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.4 –Identify contraindications, warnings, and precautions associated with a
drug product’s active and inactive ingredients.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Principles of Drug
Action
I
L
T, Q, RP
Med. Chem. I
I
L
T
DSM – I
I
L, CS
T
Med. Chem. II
I
L
T
Pharmacy
Practice
E
CS
Q, RP, OP, IGP,
Lab
15
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.4 –Identify contraindications, warnings, and precautions associated with a
drug product’s active and inactive ingredients.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM – II
R
L
T
DSM – III
R, E
L, CS
T, IGP
IPPE – III
R
SGD, O
IGP, OP
Clinical Rotation
R, E
SGD, CS, O
Q, OP, IGP, D
16
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.5 –Identify physiochemical properties of drug substances that affect their
solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic
actions and stability.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Principles of Drug
Action
I
L
T, Q, RP
Pharmaceutics I
I
L
Lab, T
Med. Chem. I
I, R
L
T
P. Sciences Lab
R
L
D, Lab, IGP
Med. Chem. II
I, R
L
T
17
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.5 –Identify physiochemical properties of drug substances that affect their
solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic
actions and stability.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Biopharmaceutics
R
L
T
Pharmacy
Practice
R
CS
Lab
DSM – II
R
L
T
Applied Kinetics
I
L
T
DSM – III
E
CS
IGP
18
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.5 –Identify physiochemical properties of drug substances that affect their
solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic
actions and stability.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
IPPE – III
R
SGD, O
OP
Clinical Rotation
R, E
CS,SGD, O
Q, D
19
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.6 – Interpret and apply pharmacodynamic and pharmacokinetic principles
to calculate and determine appropriate drug dosing regimens.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Principles of Drug
Action
I
L
RP, T, Q
P. Sciences Lab
R
L
IGP, Lab, D
Biopharmaceutics
I
L
T, HW, D
Pharmacy
Practice
E
L, CS
T, Lab
DSM – II
R
L
T
20
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.6 – Interpret and apply pharmacodynamic and pharmacokinetic principles
to calculate and determine appropriate drug dosing regimens.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Applied Kinetics
I
L
T
DSM – III
I, E
L, CS
T, IGP
IPPE – III
R
O, SGD
IGP, OP
Clinical Rotation
R, E
SGD, CS, O
Q, OP, D
21
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.7 – Interpret and apply biopharmaceutic principles and the pharmaceutical
characteristics of drug dosage forms and delivery systems, to assure
bioavailability and enhance patient compliance.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Principles of Drug
Action
I
L
T, Q, RP
Pharmaceutics I
I, R
L
T, Lab
Biopharmaceutics
I
L
HW, T
Pharmacy
Practice
E
VT, CS, GS
OP, IGP, Lab
DSM – II
R
L
T
22
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.7 – Interpret and apply biopharmaceutic principles and the pharmaceutical
characteristics of drug dosage forms and delivery systems, to assure
bioavailability and enhance patient compliance.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Applied Kinetics
R
L
T
DSM – III
E
CS
IGP
IPPE – III
R
SGD
OP
Clinical Rotation
R, E
SGD, CS, O
Q, OP, D
23
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.1 – Identify pharmacotherapeutic outcomes and endpoints.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM – I
I
L
T
Med. Chem. II
?
L
T
Pharmacy
Practice
R
CS
IGP, Lab
DSM – II
R
L
T
DSM – III
I, E
CS, L
T, IGP
24
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.1 – Identify pharmacotherapeutic outcomes and endpoints.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
IPPE – III
R
SGD
OP
Clinical Rotation
R, E
SGD, O
Q, OP, D
25
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.2 – Evaluate patient signs and symptoms, and the results of monitoring
tests and procedures to determine the safety and effectiveness of
pharmacotherapy.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM – I
I
L, CS
T
DSM – II
R
L
T
DSM – III
I, E
L, CS
T, IGP
IPPE – III
R
SGD, O
OP, IGP
Clinical Rotation
R, E
SGD, O
OP, T, Q, D
26
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.3 – Identify, describe the mechanism of, and remedy adverse reactions,
allergies, side effects and iatrogenic or drug-induced illness.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Biochemistry
I
L
T
Med. Chem. I
I
L
T
Med. Chem. II
I
L
T
Pharmacy
Practice
R
CS
Lab
DSM – II
R
L
T
27
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.3 – Identify, describe the mechanism of, and remedy adverse reactions,
allergies, side effects and iatrogenic or drug-induced illness.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM – III
I, E
L, CS
IGP
IPPE – III
R
O, SGD
OP
Clinical Rotation
R, E
SGD, CS, O
RP, OP, D
28
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.4 – Prevent, recognize, and remedy medication non-adherence, misuse or
abuse.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM – I
I
L
T
Pharmacy
Practice
E
CS
IGP, Lab
DSM – II
R
L
T
DSM – III
I, E
L, CS
IGP
IPPE – III
I
O, SGD
OP, RP
Clinical Rotation
R, E
SGD, O
OP, D
29
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.5 – Recommend pharmacotherapeutic alternatives.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Med. Chem. I
I
L
T
DSM – I
I
L, CS
T
Med. Chem. II
I
L
T
DSM – II
R
L
T
30
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.5 – Recommend pharmacotherapeutic alternatives.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM – III
I, E
L, CS
T, IGP
IPPE – III
R
SGD, O
OP, IGP
Clinical Rotation
R, E
SGD, O
OP, T, Q, IGP, D
31
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 – Perform calculations required to compound, dispense, and administer
medication.
2.1.1 – Calculate the quantity of medication to be compounded or dispensed;
reduced and enlarge formulation quantities and calculate the quantity of
ingredients needed to compound the proper amount of the preparation.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmaceutics I
R
L
Lab, T
Pharmacy
Practice
E
L
Lab
IPPE – III
I
SGD
?
32
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 – Perform calculations required to compound, dispense, and administer
medication.
2.1.2 – Calculate nutritional needs and the caloric content of nutrient sources.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy
Practice
E
CS
Lab
33
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 – Perform calculations required to compound, dispense, and administer
medication.
2.1.3 – Calculate the rate of drug administration.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Biopharmaceutics
I
L
T, Q, HW
Pharmacy
Practice
E
CS
Lab
DSM – II
R
L
T
Applied Kinetics
R
L
T
34
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 – Perform calculations required to compound, dispense, and administer
medication.
2.1.4 – Calculate or convert drug concentrations, ratio strengths, and/or extent
of ionization.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmaceutics I
I, R
L
T, Lab
Biopharmaceutics
R
L
T, HW
Pharmacy
Practice
E
L, CS
Lab
Applied Kinetics
R
L
T
35
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe and
effective use.
2.2.1 – Identify drug products by their generic, brand, and/or common names.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Med. Chem. I
I
L
T
DSM – I
R
L
T
Med. Chem. II
I
L
T
Pharmacy
Practice
E
O
Q
DSM – II
R
L
T
36
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe and
effective use.
2.2.1 – Identify drug products by their generic, brand, and/or common names.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM – III
R
L
T
Pharmacy Law
R
L
T
IPPE – III
R
SGD
OP
Clinical Rotation
R, E
SGD, O
T, Q, OP, IGP, O
37
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe and
effective use.
2.2.2 – Determine whether a particular drug dosage strength or dosage form is
commercially available, and whether it is available on a nonprescription basis.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
DSM - I
I
L
?
Pharmacy
Practice
E
O
Q
DSM – II
R
L
T
DSM – III
R
L
?
38
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe and
effective use.
2.2.2 – Determine whether a particular drug dosage strength or dosage form is
commercially available, and whether it is available on a nonprescription basis.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy Law
R
L
T
IPPE - III
R
SGD
OP
Clinical Rotation
I, E
SGD, O
OP, HW, O
39
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe and
effective use.
2.2.3 – Identify commercially available drug products by their characteristic
physical attributes.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Clinical Rotation
E
SGD, O
OP, O
40
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe and
effective use.
2.2.4– Interpret and apply pharmacokinetic parameters and quality assurance
data to determine equivalence among manufactured drug products, and identify
products for which documented evidence of inequivalence exists.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Biopharmaceutics
I
L
T, HW
Applied Kinetics
R
L
T
IPPE – III
R
SGD
?
Clinical Rotation
E
O
O
41
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe and
effective use.
2.2.5 – Identify and communicate appropriate information regarding packaging,
storage, handling, administration, and disposal of medications.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Principles of Drug
Action
I
L
RP, Q, T
DSM – I
I
L
?
Biopharmaceutics
R
L
T, HW
Pharmacy
Practice
E
O
Q
42
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe and
effective use.
2.2.5 – Identify and communicate appropriate information regarding packaging,
storage, handling, administration, and disposal of medications.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy Law
E
L
T
IPPE – III
I
SGD
?
Clinical Rotation
I, E
SGD,O
OP, D, O
43
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe and
effective use.
2.2.6 – Identify and describe the use of equipment and apparatus required to
administer medications.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Calculations
I
L
T, Q, HW
DSM – I
I
L
?
Pharmacy
Practice
E
CS
Q, OP, IGP, D, O
Applied Kinetics
I
L
T
IPPE – III
I
SGD
O
Clinical Rotation
E
SGD, O
O
44
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 – Prepare and compound extemporaneous preparations and sterile
products.
2.3.1 – Identify and describe techniques and procedures related to drug
preparation, compounding and quality assurance.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmaceutics I
E
L
T, Lab
Rsch. & Lit. Eval. I E
L
T, RP
Pharmacy Law
R
L
T
IPPE – III
I
GS
?
45
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 – Prepare and compound extemporaneous preparations and sterile
products.
2.3.2 – Identify and use equipment necessary to prepare and
extemporaneously compound medications.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Calculations
I
L
HW, T, Q
Pharmaceutics I
E
L
T, Lab
IPPE – III
I
GS
?
46
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 – Prepare and compound extemporaneous preparations and sterile
products.
2.3.3 – Identify the important physiochemical properties of a preparation’s
active and inactive ingredients; describe the mechanism of, and the
characteristic evidence of incompatibility or degradation; and identify methods
for achieving stabilization of the preparation
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Biochemistry
I
L
T
Principles of Drug
Action
I
L
T, Q,RP
Pharmaceutics I
I, R
L
T, Lab
Med. Chem. I
I, R
L
T
47
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 – Prepare and compound extemporaneous preparations and sterile
products.
2.3.3 – Identify the important physiochemical properties of a preparation’s
active and inactive ingredients; describe the mechanism of, and the
characteristic evidence of incompatibility or degradation; and identify methods
for achieving stabilization of the preparation
Course
CBCO
Teaching
method(s)
Assessment
method(s)
P. Sciences Lab
R
L
D, Lab, IGP
Med. Chem. II
I
L
T
IPPE – III
I
GS
?
48
Area 3 - Provide Health Care Information and
Promote Public Health
3.1.0 – Access, evaluate, and apply information to promote optimal health care.
3.1.1 – Identify the typical content and organization of specific sources of drug
and health information for both health care providers and consumers.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
PSL – I
I
L, SGD, O
RP, P, OP, HW,
IGP
IPPE – III
I
SGD
IGP
Clinical Rotation
I, R, E
O, SGD
OP, O
49
Area 3 - Provide Health Care Information and
Promote Public Health
3.1.0 – Access, evaluate, and apply information to promote optimal health care.
3.1.2 – Evaluate the suitability, accuracy, and reliability of information from
reference sources by explaining and evaluating the adequacy of experimental
design and by applying and evaluating statistical test and parameters.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
PSL – I
I
O, SGD, L
IGP, HW, OP, P,
RP
Biopharmaceutics
R
L
T
IPPE – III
I
SGD
RP, OP, IGP
Clinical Rotation
R, E
O, CS, SGD
O, OP
50
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 – Educate the public and health care professionals regarding medical
conditions, wellness, dietary supplements, and medical devices.
3.2.1 – Provide health care information regarding the prevention and treatment
of diseases and medical conditions, including emergency patient care.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy Law
R
L
T
IPPE – III
I
SGD
IGP
Clinical Rotation
R, E
O, SGD
D, HW, OP
51
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 – Educate the public and health care professionals regarding medical
conditions, wellness, dietary supplements, and medical devices.
3.2.2 – Provide health care information regarding nutrition, lifestyle, and other
non-drug measures that are effective in promoting health or preventing or
minimizing the progression of a disease or medical condition.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Biochemistry
I
L
T
Pharmacy
Practice
R
CS
OP, IGP
Pharmacy Law
R
L
T
IPPE – III
I
SGD
?
Clinical Rotation
R, E
SGD, O
OP, D
52
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 – Educate the public and health care professionals regarding medical
conditions, wellness, dietary supplements, and medical devices.
3.2.3 – Provide information regarding the documented uses, adverse effects
and toxicities of dietary supplements.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy
Practice
E
CS
RP, OP, IGP
Pharmacy Law
R
L
T
IPPE – III
I
SGD
?
Clinical Rotation
R, E
SGD, CS, O
OP, IGP, D
53
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 – Educate the public and health care professionals regarding medical
conditions, wellness, dietary supplements, and medical devices.
3.2.4 – Provide information regarding the selection, use and care of
medical/surgical appliances and devices, self-care products, and durable
medical equipment, as well as products and techniques for self-monitoring of
health status and medical conditions.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy Law
R
L
T
Clinical Rotation
R, E
SGD, O
OP, D
54